Pozen
POZEN Inc. was a specialty pharmaceutical company headquartered in Chapel Hill, North Carolina, founded in 1996 and focused on developing therapeutics for pain and pain-related conditions, most notably acute migraine. It was best known for the products Treximet (sumatriptan/naproxen) and Vimovo (naproxen/esomeprazole). POZEN traded publicly on NASDAQ under the ticker POZN and in 2016 combined with Tribute Pharmaceuticals to form Aralez Pharmaceuticals. Pozen was surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network as a stub. As a pharmaceutical company it operated no public developer program, API, or SDK surface; an enrichment pass confirmed no API artifacts exist to harvest.
Pozen is profiled on the APIs.io network. Tagged areas include Company, Pharmaceutical, Healthcare, Biotech, and Migraine.